(561) 802-3060 info@mri-news.com

Consider enrolling in the EMMPACT study.

This study is researching how effective an investigational study drug is at helping people with confirmed or suspected NASH and fibrosis. Other study requirements apply.

Study participants receive at no cost:

• Possible access to the study drug
• Some participants will receive placebo, which has no active ingredients
• Study support and monitoring by a healthcare team
• Education about NASH and fibrosis
• The opportunity to help advance NASH research

For more information, or to learn if you may qualify to participate in this study, call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit:  https://www.metabolic-institute.com/nash-clinical-trial